Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles

Camille Tumiotto, Bruna M. Alves, Patricia Recordon-Pinson, Marine Jourdain, Pantxika Bellecave, Gwenda-Line Guidicelli, Jonathan Visentin, Fabrice Bonnet, Mojdan Hessamfar, Didier Neau, Jorge Sanchez, Christian Brander, Mohammad Sajadi, Lindsay Eyzaguirre, Esmeralda A. Soares, Jean-Pierre Routy, Marcelo A. Soares, Hervé Fleury

Open source

DOI: 10.1371/journal.pone.0212347
Published: 2019-02-27
Container: PLOS ONE
Publisher: Public Library of Science (PLoS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0212347,
  title = {Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles},
  author = {Camille Tumiotto and Bruna M. Alves and Patricia Recordon-Pinson and Marine Jourdain and Pantxika Bellecave and Gwenda-Line Guidicelli and Jonathan Visentin and Fabrice Bonnet and Mojdan Hessamfar and Didier Neau and Jorge Sanchez and Christian Brander and Mohammad Sajadi and Lindsay Eyzaguirre and Esmeralda A. Soares and Jean-Pierre Routy and Marcelo A. Soares and Hervé Fleury},
  year = {2019},
  journal = {PLOS ONE},
  doi = {10.1371/journal.pone.0212347},
  url = {https://doi.org/10.1371/journal.pone.0212347}
}

RIS

TY  - JOUR
TI  - Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles
AU  - Camille Tumiotto
AU  - Bruna M. Alves
AU  - Patricia Recordon-Pinson
AU  - Marine Jourdain
AU  - Pantxika Bellecave
AU  - Gwenda-Line Guidicelli
AU  - Jonathan Visentin
AU  - Fabrice Bonnet
AU  - Mojdan Hessamfar
AU  - Didier Neau
AU  - Jorge Sanchez
AU  - Christian Brander
AU  - Mohammad Sajadi
AU  - Lindsay Eyzaguirre
AU  - Esmeralda A. Soares
AU  - Jean-Pierre Routy
AU  - Marcelo A. Soares
AU  - Hervé Fleury
PY  - 2019
JO  - PLOS ONE
DO  - 10.1371/journal.pone.0212347
UR  - https://doi.org/10.1371/journal.pone.0212347
ER  -

APA

Tumiotto, C., Alves, B. M., Recordon-Pinson, P., Jourdain, M., Bellecave, P., Guidicelli, G., Visentin, J., Bonnet, F., Hessamfar, M., Neau, D., Sanchez, J., Brander, C., Sajadi, M., Eyzaguirre, L., Soares, E. A., Routy, J., Soares, M. A., & Fleury, H. (2019). Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles. PLOS ONE. https://doi.org/10.1371/journal.pone.0212347

Source records

crossref · retrieved 2026-09-25T13:48:30.716Z